Smallpox vaccines for biodefense: need and feasibility

@article{Artenstein2008SmallpoxVF,
  title={Smallpox vaccines for biodefense: need and feasibility},
  author={A. Artenstein and J. Grabenstein},
  journal={Expert Review of Vaccines},
  year={2008},
  volume={7},
  pages={1225 - 1237}
}
  • A. Artenstein, J. Grabenstein
  • Published 2008
  • Medicine
  • Expert Review of Vaccines
  • Smallpox, eradicated as a cause of natural disease through an intensive global effort in the later part of the 20th Century, has resurfaced as a possible agent of bioterrorism. For this reason, there is renewed interest in smallpox vaccines. Live vaccinia virus, an orthopoxvirus related to smallpox, has a long and successful clinical track record as an effective smallpox vaccine; however, its use is associated with uncommon yet serious adverse events. This has led to a surge of recent research… CONTINUE READING

    Topics from this paper.

    Genome-wide genetic associations with IFNγ response to smallpox vaccine
    • 38
    Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
    • 25
    • PDF
    The evolutionary biology of poxviruses.
    • 87
    Anti-Infectious Human Vaccination in Historical Perspective
    • 15

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 131 REFERENCES